期刊文献+

血小板膜GpⅣ、GpⅤ在慢性ITP发病中的意义 被引量:1

The Pathogenetic Signifiance of Platelet Glycoprotein Ⅳ and Glycoprotein Ⅴ in Chronic Idiopathic Thrombocytopenic Purpura
下载PDF
导出
摘要 目的:了解血小板GpⅣ、GpⅤ在慢性ITP发病中的意义。方法:采用改良的单克隆抗体免疫固定特异血小板抗原(MAIPA)的方法检测38例慢性ITP患者血浆抗GpⅣ、GPⅤ抗体水平,评估GpⅣ、GpⅤ在慢性ITP中的意义。结果:在38例患者中,1例抗GpⅤ抗体阳性,阳性率为2.6%;2例抗GpⅣ抗体阳性,阳性率为5.3%,并且在这2例患者中,1例同时存在血浆抗GpⅡb/Ⅲa抗体。结论:(1)GpⅣ是慢性ITP自身抗体的一个靶抗原,并且在某些患者体内可同时存在抗GHⅡb/Ⅲa自身抗体。(2)在慢性ITP,GpⅤ分子上亦含有自身抗体的靶抗原。 Objective: To clarify the pathgcnctic importance of platelet GpⅣ and GpⅤ in chronic idio-pathic thrombocytopenic purpura( ITP). Methods: The plasma autoantibodies against GpⅣ or GpⅤ in patients with chronic TTP(n=38) were measured by using a modified monoclonal antibody specific immobilization of platelet antigens(MAIPA) assay. The pathogenetic importance of GpⅣ and GpⅤ in chronic ITP was valuated. Results: In 38 patients with chronic ITP, specific antibodies against GpⅣ were found in two patients, and was coexist with antoantibodies against Gp Ⅱb/Ⅲa in one patient; GpⅤ-specific antibodies were found in one patients. The positive rate were 5.3% and 2. 6% respectively. Conclusion: (1)GpⅣ was a target antigen of plasma antuantibodies in chronic ITP, and was coexist with Gp Ⅱ b/Ⅲa antoantigen in some patients. (2)GpⅤ was an important scarce target antigen in chronic ITP.
出处 《血栓与止血学》 2001年第4期153-154,157,共3页 Chinese Journal of Thrombosis and Hemostasis
关键词 慢性ITP GpⅣ GpⅤ MAIPA Chronic ITP GpⅣ GpⅤ Modified MAIPA
  • 相关文献

参考文献6

  • 1Wadenvik H,Stockelberg D,Kutti J.Autoantibody specificity and frequency in chronic immune thrombocytopenia[].Thrombosis and Haemostasis.1993
  • 2Kunicki TL,Newman PL.The molecular immunology of human piatelet proteins[].Blood.1992
  • 3Mayer JL,Beardsley DS.Varicella-aaociated thronbocytopenic: antoantibodies against platelet surfare glycoprotein V[].Pediatric Research.1996
  • 4He R,Reid DM,Jones CE,et al.Spectrum of Ig classes, specificities,and titers of surem antiglycoprotem in chronic idiopathic thrombocytopenic purpura[].Blood.1994
  • 5Hou M,Stockelberg D,Kutti J,et al.Antibodies against platelet GpⅠ b/Ⅸ, Gp Ⅱ b/Ⅲ a, and other platelet antigens in chronic idiopathic thrombocytopenic purpura[].European Journal of Haematology.1995
  • 6Kiefel V. Santoso S,Weisheit M,et al.Monoclonal antibody-specific immobilization of platelet antigens(MAIPA): a new tool for the identification of platelet-reactive antibodies[].Blood.1987

同被引文献35

  • 1Kuwana M, Nomura S, Fujimura K, et al. Effect of a single injection of humanized anti-CD154 monoclonal antibody on the plateletspecific autoimmune response in patients with immune thrombocytopenic purpura. Blood, 2004; 103:1229 1236
  • 2Kuwana M, Okazaki Y, Kajihara M, et al. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum, 2002; 46:2148 2159
  • 3Hou M, Rosengren-Kogan L, Forberg B, et al. Genotyping of the platelet-specific alloantigen HPA-5 (Br(a)/Br(b) ) using polymerase chain reaction with sequence specific primers (PCR-SSP). Eur J Haematol, 1996; 57: 208- 213
  • 4Stockelberg D, Hou M, Jacobsson S, et al. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura. A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA. Eur J Haematol, 1996; 56:72 - 77
  • 5Hou M, Stockelberg D, Kutti J, et al. Immunoglobulin targeting both GPⅡb/Ⅲ a and GP Ⅰb/Ⅸ in chronic idiopathic thrombocytopenic purpura(ITP): evidence for at least two different IgG antibodies. Br J Haematol, 1997; 98: 64 - 67
  • 6Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346:995 - 1008
  • 7Hou M, Stockberg D, Kutti J, et al. Naturally occurring IgG autoantibodies to platelet cytoskeleton tropomyosin. Thromb Haemost, 1996; 75 .. 642 - 647
  • 8Wadenvik H, Stockelberg D, Hou M. Platelet proteins as autoantibody targets in idiopathic thrombocytopenic purpura. Acta Paediatrsuppl, 1998; 424: 26-36
  • 9Kim J, Park CJ, Chi HS, et al. Idiopathic thrombocytopenic purpura: better therapeutic responses of patients with B- or T-cell clonality than patients without clonality. Int J Hematol, 2003; 78:461 - 466
  • 10McMillan R. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura. Semin Hematol, 2000; 37(1 Suppl 1):5-9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部